Intake of Japanese and Chinese teas reduces risk of Parkinson's disease

Parkinsonism and Related Disorders

Volumn 17, Issue 6, 2011, Pages 446-450

  Tanaka, Keiko ^a   Miyake, Yoshihiro ^a   Fukushima, Wakaba ^b   Sasaki, Satoshi ^c   Kiyohara, Chikako ^d   Tsuboi, Yoshio ^a   Yamada, Tatsuo ^a   Oeda, Tomoko ^e   Miki, Takami ^b   Kawamura, Nobutoshi ^d   Sakae, Nobutaka ^d   Fukuyama, Hidenao ^f   Hirota, Yoshio ^b   Nagai, Masaki ^g  

^a FUKUOKA UNIVERSITY   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e UTANO NATIONAL HOSPITAL   (Japan)

^f KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Caffeine; Case control studies; Coffee; Japan; Parkinson's disease

Indexed keywords

AGED; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHINESE; CLINICAL ASSESSMENT; COFFEE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; HUMAN; JAPAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK REDUCTION; SMOKING HABIT; TEA;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CAFFEINE; CASE-CONTROL STUDIES; CHINA; COFFEE; DIET; FEMALE; HUMANS; JAPAN; MALE; PARKINSON DISEASE; RISK FACTORS; TEA;

EID: 79959345557     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.02.016     Document Type: Article

References (30)

1. de Lau L.M., Breteler M.M. Epidemiology of Parkinson's disease. Lancet Neurol 2006, 5:525-535.
2. Logroscino G. The role of early life environmental risk factors in Parkinson disease: what is the evidence?. Environ Health Perspect 2005, 113:1234-1238.
3. Tanner C.M., Ottman R., Goldman S.M., Ellenberg J., Chan P., Mayeux R., et al. Parkinson disease in twins: an etiologic study. J Am Med Assoc 1999, 281:341-346.
4. Wirdefeldt K., Gatz M., Schalling M., Pedersen N.L. No evidence for heritability of Parkinson disease in Swedish twins. Neurology 2004, 63:305-311.
5. Fall P.A., Fredrikson M., Axelson O., Granérus A.K. Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden. Mov Disord 1999, 14:28-37.
6. Ross G.W., Abbott R.D., Petrovitch H., Morens D.M., Grandinetti A., Tung K.H., et al. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 2000, 283:2674-2679.
7. Benedetti M.D., Bower J.H., Maraganore D.M., McDonnell S.K., Peterson B.J., Ahlskog J.E., et al. Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology 2000, 55:1350-1358.
8. Paganini-Hill A. Risk factors for Parkinson's disease: the leisure world cohort study. Neuroepidemiology 2001, 20:118-124.
9. Ascherio A., Zhang S.M., Hernán M.A., Kawachi I., Colditz G.A., Speizer F.E., et al. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol 2001, 50:56-63.
10. Tan E.K., Tan C., Fook-Chong S.M., Lum S.Y., Chai A., Chung H., et al. Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese. J Neurol Sci 2003, 216:163-167.
11. Ascherio A., Weisskopf M.G., O'Reilly E.J., McCullough M.L., Calle E.E., Rodriguez C., et al. Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen. Am J Epidemiol 2004, 160:977-984.
12. Hernán M.A., Takkouche B., Caamaño-Isorna F., Gestal-Otero J.J. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 2002, 52:276-284.
13. Costa J., Lunet N., Santos C., Santos J., Vaz-Carneiro A. Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies. J Alzheimers Dis 2010, 20:S221-S238.
14. Preux P.M., Condet A., Anglade C., Druet-Cabanac M., Debrock C., Macharia W., et al. Parkinson's disease and environmental factors. Matched case-control study in the Limousin region, France. Neuroepidemiology 2000, 19:333-337.
15. Checkoway H., Powers K., Smith-Weller T., Franklin G.M., Longstreth W.T., Swanson P.D. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 2002, 155:732-738.
16. Ascherio A., Chen H., Schwarzschild M.A., Zhang S.M., Colditz G.A., Speizer F.E. Caffeine, postmenopausal estrogen, and risk of Parkinson's disease. Neurology 2003, 60:790-795.
17. Wirdefeldt K., Gatz M., Pawitan Y., Pedersen N.L. Risk and protective factors for Parkinson's disease: a study in Swedish twins. Ann Neurol 2005, 57:27-33.
18. Tan L.C., Koh W.P., Yuan J.M., Wang R., Au W.L., Tan J.H., et al. Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study. Am J Epidemiol 2008, 167:553-560.
19. Chan D.K., Woo J., Ho S.C., Pang C.P., Law L.K., Ng P.W., et al. Genetic and environmental risk factors for Parkinson's disease in a Chinese population. J Neurol Neurosurg Psychiatry 1998, 65:781-784.
20. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992, 55:181-184.
21. Standard tables of food composition in Japan, 5th revised and enlarged ed. Tokyo 2005, Science and Technology Agency, Printing Bureau of the Ministry of Finance, (in Japanese).
22. Standard tables of food composition in Japan, Fatty Acids Section, 5th revised and enlarged ed. Tokyo 2005, Science and Technology Agency, Printing Bureau of the Ministry of Finance, (in Japanese).
23. Yamada M., Sasaki S., Murakami K., Takahashi Y., Okubo H., Hirota N., et al. Estimation of caffeine intake in Japanese adults using 16 d weighed diet records based on a food composition database newly developed for Japanese populations. Public Health Nutr 2010, 13:663-672.
24. Willett W., Stampfer M.J. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986, 124:17-27.
25. Fredholm B.B., Bättig K., Holmén J., Nehlig A., Zvartau E.E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 1999, 51:83-133.
26. Kanda T., Tashiro T., Kuwana Y., Jenner P. Adenosine A2A receptors modify motor function in MPTP-treated common marmosets. Neuroreport 1998, 9:2857-2860.
27. Chen J.F., Xu K., Petzer J.P., Staal R., Xu Y.H., Beilstein M., et al. Neuroprotection by caffeine and A2A adenosine receptor inactivation in a model of Parkinson's disease. J Neurosci 2001, 21:RC143.
28. Wang G.J., Volkow N.D., Fowler J.S. The role of dopamine in motivation for food in humans: implications for obesity. Expert Opin Ther Targets 2002, 6:601-609.
29. Abbott R.D., Petrovitch H., White L.R., Masaki K.H., Tanner C.M., Curb J.D., et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001, 57:456-462.
30. Ponsen M.M., Stoffers D., Booij J., van Eck-Smit B.L., ECh Wolters, Berendse H.W. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 2004, 56:173-181.